Key result
This article provides a review of the pathogenesis and novel treatments for septic shock in pediatric patients.
May inform awareness of novel pediatric septic shock therapies; leaves open their clinical role pending prospective trials.
*Associate Director, Medical-Surgical Intensive Care Unit, Children’s Hospital Boston, and Assistant Professor of Anaesthesia (Pediatrics), Harvard Medical School, Boston, Massachusetts. EDITORS’ NOTE: This article is the second of six that will be published in 2003 for which a total of up to 6 category 1 CME credits can be earned. Instructions for how credits can be earned appear on the last page of the Table of Contents. Dr. Burns has disclosed that he has no significant relationships with or financial interests in any commercial companies that pertain to this educational activity. Address for reprints: Jeffrey Burns, MD, MPH, Medical-Surgical Intensive Care Unit Office/Farley 517, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115-5724; e-mail: [email protected]
No takes yet. Share an insight, caveat, or question.
Jeffrey P. Burns (2003) conducted a review in Septic shock in pediatric patients. This article provides a review of the pathogenesis and novel treatments for septic shock in pediatric patients.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: